TrialThe Journal of infectious diseases2019

Immunogenicity, Lot Consistency, and Extended Safety of rVSVΔG-ZEBOV-GP Vaccine: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study in Healthy Adults.

Scott A Halperin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.